Western Blotting Market is projected to reach USD 1.4 billion by 2026 from USD 1.0 billion in 2021, at a CAGR of 6.7% during the forecast period.  Western blotting is an essential laboratory technique used to detect and analyze proteins. It is used in a variety of fields, from diagnosing and monitoring diseases to environmental testing. The global western blotting market is expected to witness significant growth over the forecast period due to increasing demand for protein detection and analysis.

The major drivers for the western blotting market include the increasing prevalence of infectious diseases, the increasing utilization of protein-based therapeutics and biotherapeutics, and the growing demand for protein research in drug discovery. Additionally, advancements in technology are expected to drive the market further. For instance, the development of automated blotting systems and the development of advanced detection reagents for western blotting are likely to propel the market.

The primary purpose of western blotting is to detect and identify proteins in a sample. It is commonly used to determine the presence of particular proteins in a sample, such as those present in a disease state or in response to a drug. Western blotting is also used to measure changes in protein abundance or post-translational modifications such as phosphorylation or glycosylation.

Get a sample of the report:  https://www.prnewswire.com/news-releases/western-blotting-market-worth-1-4-billion-by-2026--exclusive-report-by-marketsandmarkets-301425220.html

Top Lading Players: Bio-Rad Laboratories, Inc. (US), Thermo Fisher Scientific (US), Danaher Corporation (US), Bio-Techne Corporation (US), and Merck KGaA (Germany)

Some Key Highlights from the Report:

  • The global western blotting market is likely to grow at a CAGR of 6.7% during 2021-2026.
  • The market is driven by factors such as the increasing prevalence of chronic diseases, rising investments in research and development activities, and growing applications of western blotting techniques.
  • The increasing demand for monoclonal antibodies, growing biotechnology industry, and technological advancements in western blotting techniques are some other factors expected to drive the market growth.
  • The reagents segment is expected to hold the largest share in the market due to its wide range of applications in western blotting techniques.
  • By end user, the market is divided into academic & research institutes, biotechnology & pharmaceutical companies, and hospitals & diagnostic centers.
  • The academic & research institutes segment is projected to be the largest segment due to the increasing investments in research and development activities.
  • North America is expected to dominate the global western blotting market due to the presence of a large number of biopharmaceutical companies, increasing prevalence of chronic diseases, and rising investments in R&D activities.

Segments covered in the report:

By Product

  • Consumables
  • Instruments

By Application

  • Biomedical Research
  • Clinical Diagnostics
  • Agricultural Applications
  • Other Applications

By End User

  • Academic & Research Institutes
  • Biopharmaceutical & Biotechnology Companies
  • Hospitals & Diagnostic Laboratories
  • Other End Users

Ask for Customize Research Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=235810711

Regional Outlook:

  • North America (U.S.A., Canada, Mexico)
  • Europe (Italy, U.K., Germany, France, Rest of Europe)
  • Asia Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
  • Latin America (Chile, Brazil, Argentina, Peru, Rest of Latin America)
  • Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Key Questions Addressed in the Report:

  1. What are the dominating factors that are influencing the growth of the industry?
  2. In the forecast period, which market segment is expected to rise the most?
  3. What are the risks and challenges that the industry is facing?
  4. In the coming years, which area is projected to dominate the market?
  5. Who are the major players in the market?
  6. What kind of strategic business plans have they made?

Make an inquiry to Buy this Report  @ https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=235810711

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Aashish Mehra

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: [email protected]